Actively Recruiting

Phase Not Applicable
Age: 65Years - 85Years
All Genders
Healthy Volunteers
ID07048860

A ICOPE Intense Program Combined With Ketone Ester Pilot Study

Led by University Hospital, Toulouse · Updated on 2025-07-23

40

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are exploring a model called ICOPE to promote healthy aging by preventing declines in immunity, mobility, and cognitive function. This pilot study aims to measure the maximum impact that a strong non-drug intervention, combined with nutritional ketone supplementation, can have on key aging functions. The findings will serve as a reference for future studies on new anti-aging drugs or other nonpharmacological approaches. Participants receive one of four treatments: the intense ICOPE program alone, the intense ICOPE program plus ketone ester supplements, the usual ICOPE Step 1 program plus ketone supplements, or the usual ICOPE Step 1 program with a placebo. The intense program includes 45 hours of center-based group sessions, daily home lifestyle improvements, and weekly support calls. Ketone ester dosing starts with 12.5g daily in the first week, increasing to 25g daily for weeks 2 through 8. Additional dietary supplements like vitamin D3, omega-3, vitamins B9 and B12, and leucine-rich whey may be provided as needed. During the 60-day study, participants will be assessed on cognitive, muscle, and immune function to estimate the size of the intervention's effects. Evaluations include physical tests, cognitive screening, and monitoring of supplement adherence. Safety and ability to participate are closely monitored, with eligibility requiring independent living and certain mobility and cognitive criteria. The total study involvement lasts about two months, focusing on how the combined interventions influence aging-related functions.

CONDITIONS

Brief Title

ICOPE INTENSE-K Pilot Study

Who Can Participate

Age: 65Years - 85Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Independent living with the ability to perform at least 5 out of 6 daily activities
  • Men and women aged between 65 and 85 years
  • Mobility impairment demonstrated by taking more than 12 seconds on a 5 Chair-rise test
  • Sedentary lifestyle spending six or more hours per day sitting or lying down
  • Positive screening for mild cognitive impairment using the ICOPE screening tool with MMSE scores between 25 and 28
  • Body mass index of 25 kg/m2 or higher
Not Eligible

You will not qualify if you...

  • Unintentional weight loss of 10% or more in the past 6 months
  • Diagnosis of dementia
  • Life-threatening illnesses with less than 1 year life expectancy as judged by a doctor
  • Severe heart conditions including advanced heart failure, aortic stenosis, history of cardiac arrest, use of cardiac defibrillator, uncontrolled angina, or any condition preventing physical activity
  • Other serious health issues that impair ability to participate, such as kidney failure on dialysis or severe psychiatric disorders (except depression)
  • Inability to participate in sessions three times per week for 60 days
  • Living in a nursing home
  • Under legal protection measures such as guardianship or curatorship

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

screening and enrollment visit

Treatment

Duration - 60 days

Participants receive the ICOPE intense program combined with dietary supplements including ketone ester or placebo over a 60-day period, involving center-based multidomain sessions, home-based lifestyle improvements, and weekly individual support calls.

Weekly visits for support calls and multiple in-person sessions over 60 days

Trial Site Locations

Total: 1 location

1

Cité de la santé - Hopital La Grave

Toulouse, France, 31059

Actively Recruiting

Loading map...

Research Team

Y

Yves ROLLAND

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

4

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here